A. Campidelli

发表

Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial

M. De Carvalho Bittencourt, L. Reppel, D. Bensoussan, 2017, Journal of Hematology & Oncology.

Comparison of NK alloreactivity prediction models based on KIR-MHC interactions in haematopoeitic stem cell transplantation

J. Trowsdale, J. Traherne, M. Rubio, 2023, Frontiers in Immunology.

Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real‐world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group

P. Feugier, L. Fornecker, A. Delmer, 2017, American journal of hematology.

Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma

P. Feugier, M. Rubio, Arnaud Campidelli, 2022, Journal of clinical medicine.

Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study.

L. Reppel, D. Bensoussan, M. D’aveni, 2018, Cytotherapy.

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group

R. Houot, L. Ysebaert, E. Gat, 2021, Blood.

Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT

L. Reppel, D. Bensoussan, Arnaud Campidelli, 2018, Bone Marrow Transplantation.

On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.

M. Robin, J. Bay, E. Forcade, 2021, Clinical lymphoma, myeloma & leukemia.

Age‐related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation

P. Feugier, A. Notarantonio, M. De Carvalho Bittencourt, 2022, British journal of haematology.

Cost Saving with Home-Based Chemotherapy Approach in Multiple Myeloma: The ADHOMY Trial

F. Guillemin, P. Feugier, H. Auge, 2021 .

A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic

N. Thilly, D. Bensoussan, A. Luc, 2023, Cytotherapy.

CAR T‐cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real‐life results of the LOC network

R. Houot, F. Davi, A. Alentorn, 2024, American journal of hematology.

[Medium-term follow-up of patients treated with chimeric antigen receptor T cells (CAR T cells): Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

I. Yakoub-Agha, P. Schneider, Tamim Alsuliman, 2021, Bulletin du cancer.

Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT

V. Decot, C. Qian, A. Campidelli, 2018, Bone Marrow Transplantation.